Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1969 Nov 29;4(5682):528–530. doi: 10.1136/bmj.4.5682.528

Influence of amphetamines on plasma corticosteroid and growth hormone levels in man

G M Besser, P W P Butler, J Landon, Lesley Rees
PMCID: PMC1630386  PMID: 4311188

Abstract

Plasma fluorogenic corticosteroid and immunoreactive growth hormone levels rose significantly after the intravenous administration of methylamphetamine to healthy young men at various times of the day. The rise in corticosteroids was most pronounced in the evening and was accompanied by an increase in circulating levels of immunoreactive corticotrophin. Oral dexamphetamine also resulted in significant rises in plasma corticosteroids but not in growth hormone. These hormonal changes were accompanied by evidence of mild central stimulation. Though they may be part of an associated and non-specific response, it is more likely that they represent specific effects of amphetamines on centres in the hypothalamus or midbrain controlling secretion of corticotrophin and growth hormone releasing factors.

Full text

PDF
528

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Besser G. M., Steinberg H. L'interaction du chlordiazépoxide et du dexamphétamine chez l'homme. Therapie. 1967 Sep-Oct;22(5):977–990. [PubMed] [Google Scholar]
  2. Blackard W. G., Heidingsfelder S. A. Adrenergic receptor control mechanism for growth hormone secretion. J Clin Invest. 1968 Jun;47(6):1407–1414. doi: 10.1172/JCI105832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Butler P. W., Besser G. M., Steinberg H. Changes in plasma cortisol induced by dexamphetamine and chlordiazepoxide given alone and in combination in man. J Endocrinol. 1968 Mar;40(3):391–392. doi: 10.1677/joe.0.0400391. [DOI] [PubMed] [Google Scholar]
  4. DICKINS D. W., LADER M. H., STEINBERG H. DIFFERENTIAL EFFECTS OF TWO AMPHETAMINE-BARBITURATE MIXTURES IN MAN. Br J Pharmacol Chemother. 1965 Feb;24:14–23. doi: 10.1111/j.1476-5381.1965.tb02076.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hunter W. M., Greenwood F. C. A radio-immunoelectrophoretic assay for human growth hormone. Biochem J. 1964 Apr;91(1):43–56. doi: 10.1042/bj0910043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. KLEIN R., LIVINGSTON S. The effect of adrenocorticotropic hormone in epilepsy. J Pediatr. 1950 Nov;37(5):733–742. doi: 10.1016/s0022-3476(50)80071-9. [DOI] [PubMed] [Google Scholar]
  7. KORNETSKY C., HUMPHRIES O. Psychological effects of centrally acting drugs in man; effects of chlorpromazine secobarbital on visual and motor behaviour. J Ment Sci. 1958 Oct;104(437):1093–1099. doi: 10.1192/bjp.104.437.1093. [DOI] [PubMed] [Google Scholar]
  8. MATTINGLY D. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol. 1962 Jul;15:374–379. doi: 10.1136/jcp.15.4.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MURPHY J. V., MILLER R. E. The effect of adrenocorticotrophic hormone (ACTH) on avoidance conditioning in the rat. J Comp Physiol Psychol. 1955 Feb;48(1):47–49. doi: 10.1037/h0043004. [DOI] [PubMed] [Google Scholar]
  10. Müller E. E., Saito T., Arimura A., Schally A. V. Hypoglycemia, stress and growth hormone release: blockade of growth hormone release by drugs acting on the central nervous system. Endocrinology. 1967 Jan;80(1):109–117. doi: 10.1210/endo-80-1-109. [DOI] [PubMed] [Google Scholar]
  11. NASMYTH P. A. The effect of some sympathomimetic amines on the ascorbic acid content of rats' adrenal glands. J Physiol. 1949 Dec;110(3-4):294–300. doi: 10.1113/jphysiol.1949.sp004439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Naumenko E. V. Role of adrenergic and cholinergic structures in the control of the pituitary-adrenal system. Endocrinology. 1967 Jan;80(1):69–76. doi: 10.1210/endo-80-1-69. [DOI] [PubMed] [Google Scholar]
  13. Shute C. C., Lewis P. R. Cholinergic and monoaminergic pathways in the hypothalamus. Br Med Bull. 1966 Sep;22(3):221–226. doi: 10.1093/oxfordjournals.bmb.a070477. [DOI] [PubMed] [Google Scholar]
  14. Silverstone J. T., Stunkard A. J. The anorectic effect of dexamphetamine sulphate. Br J Pharmacol Chemother. 1968 Jul;33(3):513–522. doi: 10.1111/j.1476-5381.1968.tb00499.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. VOGT M. EFFECT OF DRUGS ON METABOLISM OF CATECHOLAMINES IN THE BRAIN. Br Med Bull. 1965 Jan;21:57–61. doi: 10.1093/oxfordjournals.bmb.a070357. [DOI] [PubMed] [Google Scholar]
  16. WEISS B., LATIES V. G. Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev. 1962 Mar;14:1–36. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES